F31
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Diagnosis of bipolar disorder (according to SCID Bipolar I or II and a diagnostic panel of two independent psychiatrists, A.P. and J.S.) • Mental and linguistic capability to participate in the study • Written informed consent.
Exclusion criteria
Exclusion criteria: Refusal to participate in the registry (in that case only the limited anonymous data set will be requested and sampled).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Description of treatment strategies including reasons for choosing and stopping certain treatments including frequency of patients treated according to current guideline suggestions. | — |
Secondary
| Measure | Time frame |
|---|---|
| • Description of health care situation of the patients including diagnostic and treatment history and comorbidities • Assessment of psychosocial functioning and quality of life of the patients and of the association with the diagnostic and treatment history as well as current treatment • Assessment of socioeconomic situation of the patients including work incapacity and assessment of health care resource utilization • Comparison of psychosocial functioning, quality of life, socioeconomic situation and health care resource utilization in patients treated with and without quetiapine (separately for immediate vs. extended release preparations). At the moment it is not possible to refer the enquiry times and the assessment instruments detailed to endpoints. This will be valued with the help of self and external assessment instruments(STAI-SF (State-Trait Anxiety Inventory), ASRM (Altman Self-rating Mania Scale), QUIDS-SR16 (Quick Inventory of Depressive Symptomatology Self-report), Q-Les-Q (Quality of Life Enjoyment and Satisfaction Questionaire), PRISE (Patient Rated Inventory of Side Effects), CGI BP (Clinical Global Impressions - Bipolar), MADRS (Montgomery Asberg Depression Scale), HAMD (Hamilton Depression Scale), YMRS (Young Mania Rating Scale), C-SSRS(Columbia Suicide Severity Rating Scale), FAST(Functionning Assessment Short Test) and cognitive testing (CVLT (California Verbal Learning Test, TMT (Trail Making Test)). Enquiry period: - within 7 days of first admission - every week during first hospitalization - within 7 days of discharge - 5 month after first admission - 11 month after first admission - 17 month after first admission - 23 month after first admission All data will be collected or updated. | — |
Countries
Germany
Contacts
Universitätsklinikum Carl Gustav Carus an der TU Dresden Klinik und Poliklinik für Psychiatrie und Psychotherapie